JPS56100784A - Indolizine derivative - Google Patents
Indolizine derivativeInfo
- Publication number
- JPS56100784A JPS56100784A JP401280A JP401280A JPS56100784A JP S56100784 A JPS56100784 A JP S56100784A JP 401280 A JP401280 A JP 401280A JP 401280 A JP401280 A JP 401280A JP S56100784 A JPS56100784 A JP S56100784A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- compound
- englobement
- analgesic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003406 indolizinyl group Chemical class C=1(C=CN2C=CC=CC12)* 0.000 title 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 230000000202 analgesic effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000001133 acceleration Effects 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003356 anti-rheumatic effect Effects 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- YYRGKNSWKVPQBS-UHFFFAOYSA-N ethyl 2,4-dioxo-4-(2-phenylindolizin-3-yl)butanoate Chemical compound C1=C2C=CC=CN2C(C(=O)CC(=O)C(=O)OCC)=C1C1=CC=CC=C1 YYRGKNSWKVPQBS-UHFFFAOYSA-N 0.000 abstract 1
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 210000002540 macrophage Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP401280A JPS56100784A (en) | 1980-01-16 | 1980-01-16 | Indolizine derivative |
EP81900262A EP0043858B1 (en) | 1980-01-16 | 1981-01-13 | Hetero ring-substituted oxoalkanoic acid derivatives |
PCT/JP1981/000007 WO1981002013A1 (en) | 1980-01-16 | 1981-01-13 | Hetero ring-substituted oxoalkanoic acid derivatives |
DE8181900262T DE3163121D1 (de) | 1980-01-16 | 1981-01-13 | Hetero ring-substituted oxoalkanoic acid derivatives |
US06/297,696 US4386092A (en) | 1980-01-16 | 1981-01-13 | Heterocyclic-substituted oxoalkanoic acid derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP401280A JPS56100784A (en) | 1980-01-16 | 1980-01-16 | Indolizine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS56100784A true JPS56100784A (en) | 1981-08-12 |
Family
ID=11573050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP401280A Pending JPS56100784A (en) | 1980-01-16 | 1980-01-16 | Indolizine derivative |
Country Status (5)
Country | Link |
---|---|
US (1) | US4386092A (ja) |
EP (1) | EP0043858B1 (ja) |
JP (1) | JPS56100784A (ja) |
DE (1) | DE3163121D1 (ja) |
WO (1) | WO1981002013A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880824A (en) * | 1987-09-21 | 1989-11-14 | Ortho Pharmaceutical Corporation | Phenyl and benzoyl substituted imidazo-fused heterocyclic calcium channel blockers |
US5260451A (en) * | 1989-05-11 | 1993-11-09 | Merckle Gmbh | Substituted pyrrole compounds and use thereof in pharmaceutical compositions |
DE3915450A1 (de) * | 1989-05-11 | 1990-11-15 | Gerd Prof Dr Dannhardt | Substituierte pyrrolverbindungen und deren anwendung in der pharmazie |
FR2699919B1 (fr) * | 1992-12-24 | 1995-01-27 | Synthelabo | Dérivés d'imidazole, leur procédé de préparation et leur application en thérapeutique. |
EP1086091A4 (en) * | 1998-06-03 | 2001-10-10 | Merck & Co Inc | HIV INTEGRASE INHIBITORS |
CA2329134A1 (en) * | 1998-06-03 | 1999-12-09 | David L. Clark | Hiv integrase inhibitors |
US6262055B1 (en) * | 1998-06-03 | 2001-07-17 | Merck & Co., Inc. | HIV integrase inhibitors |
US6380249B1 (en) | 1998-06-03 | 2002-04-30 | Merck & Co., Inc. | HIV integrase inhibitors |
US6306891B1 (en) * | 1998-06-03 | 2001-10-23 | Merck & Co., Inc. | HIV integrase inhibitors |
GB9816358D0 (en) * | 1998-07-27 | 1998-09-23 | Angeletti P Ist Richerche Bio | Enzyme inhibitors |
WO2000006529A1 (en) | 1998-07-27 | 2000-02-10 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti S.P.A. | Diketoacid-derivatives as inhibitors of polymerases |
AP2001002169A0 (en) | 1998-12-25 | 2001-06-30 | Shionogi & Co | Aromatic heterocycle compounds having hiv intergrase inhibiting activities |
DE10004157A1 (de) | 2000-02-01 | 2001-08-02 | Merckle Gmbh Chem Pharm Fabrik | 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie |
ATE482208T1 (de) * | 2004-03-10 | 2010-10-15 | Us Of America Represented By T | Chinolin-4-one als inhibitoren der retroviralen integrase zur behandlung von hiv, aids und aids- related complex (arc) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1076089A (en) * | 1965-11-09 | 1967-07-19 | Selvi & C Lab Bioterapico | New derivatives of imidazo [1,2-a]-pyridine and a process for the manufacture thereof |
CH621126A5 (ja) * | 1974-02-07 | 1981-01-15 | Plantex Ltd | |
GB1493043A (en) * | 1975-11-19 | 1977-11-23 | Auto Security Prod Ltd | Locking device |
-
1980
- 1980-01-16 JP JP401280A patent/JPS56100784A/ja active Pending
-
1981
- 1981-01-13 DE DE8181900262T patent/DE3163121D1/de not_active Expired
- 1981-01-13 US US06/297,696 patent/US4386092A/en not_active Expired - Fee Related
- 1981-01-13 WO PCT/JP1981/000007 patent/WO1981002013A1/ja active IP Right Grant
- 1981-01-13 EP EP81900262A patent/EP0043858B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0043858A4 (en) | 1982-05-10 |
EP0043858A1 (en) | 1982-01-20 |
DE3163121D1 (de) | 1984-05-24 |
EP0043858B1 (en) | 1984-04-18 |
WO1981002013A1 (en) | 1981-07-23 |
US4386092A (en) | 1983-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS56100784A (en) | Indolizine derivative | |
JPS5788170A (en) | Thiazolidone derivative | |
JPS57192342A (en) | Isoprenylamine derivative | |
JPS57192340A (en) | Isoprenylamine derivative | |
JPS5711986A (en) | Okadaic acid, its salt, and its ester | |
JPS5535066A (en) | Novel pyrazole derivative | |
JPS55151549A (en) | Production of guanidinocaproic ester | |
JPS57212188A (en) | Imidazobenzoxazine derivative and its preparation | |
JPS5798232A (en) | 1-(6-methoxy-2-naphthyl)-2-oxy-1-alkanone acetal | |
JPS554334A (en) | Pyranopyrazole derivative | |
JPS55105643A (en) | Novel cyclohexanecarboxylic acid derivative | |
JPS57131738A (en) | Novel cyclohexanecarboxylic acid derivative | |
JPS5750952A (en) | Benzoic acid derivative | |
JPS55143973A (en) | Phenylacetic acid derivative | |
JPS572257A (en) | Preparation of 4-hydroxybenzylnitrile derivative | |
JPS5527161A (en) | Production of alcohol or its ether derivative | |
JPS57131780A (en) | Novel 6-oxabicyclo(3.2.1)octan-7-one derivative | |
JPS57131745A (en) | Novel cyclohexanecarboxylic acid derivative | |
JPS54130599A (en) | Furoindole derivative | |
JPS5639074A (en) | Pyrimidine derivative | |
JPS5716840A (en) | Phneylacetic acid derivative | |
JPS5731656A (en) | S-alkyl-n-acetyl-cysteinamide and its preparation | |
JPS55104216A (en) | Production of substituted arylacetic acid derivative | |
JPS5515426A (en) | Pyranopyrrole derivative | |
JPS57171946A (en) | Novel oxyacetic acid derivative, its preparation, and blood lipid level depressing agent containing said derivative as active component |